A new ALTC Product Bulletin is available now. In this supplement, we cover the topic of fecal incontinence in long-term care and treatment with Solesta. Download the PDF today and use it as a handy reference in your clinical practice.
As patients age, the probability of fecal incontinence increases greatly. Almost 50% of the elderly residing in nursing homes suffer from bouts of fecal incontinence. Some elders are unlikely to report fecal incontinence to their healthcare providers due to embarrassment or believing that it is a normal occurrence of aging. However, the condition can be burdensome on activities of daily living and may be indicative of a serious underlying condition, such as poor diet, diarrhea, constipation, or damage to the rectum or rectal walls. When dietary changes or antimotility medication have failed, patients have another treatment option. Manufactured by Oceana Therapeutics, Solesta is a biocompatible tissue bulking gel that is injected into the layer of tissue underneath the anus.